"This change recognizes the specialized nature of contrast-enhanced ultrasound technology and ensures appropriate payment for these services, " according to the final rule promulg ...

Acoustic droplet vapourisation (ADV) and phase‐change contrast agents (PCCAs) represent a promising frontier in biomedical ultrasound technology. By employing focused ultrasound, liquid ...